Literature DB >> 15015977

Treatment of beta-thalassaemia-associated osteoporosis with zoledronic acid.

Vasilios Perifanis, Timos Vyzantiadis, Sofia Vakalopoulou, Konstantinos Tziomalos, Vasilia Garypidou, Miranta Athanassiou-Metaxa, Fedon Harsoulis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15015977     DOI： 10.1111/j.1365-2141.2004.04871.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Bisphosphonates in the treatment of thalassemia-associated osteoporosis.

Authors:  A Gaudio; N Morabito; A Xourafa; I Macrì; A Meo; S Morgante; A Trifiletti; A Lasco; N Frisina
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

Review 2.  Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review.

Authors:  M Mamtani; H Kulkarni
Journal:  Osteoporos Int       Date:  2009-02-26       Impact factor: 4.507

Review 3.  Molecular Aspects of Bone Resorption in β-Thalassemia Major.

Authors:  Najmaldin Saki; Saeid Abroun; Fatemeh Salari; Fakher Rahim; Mohammad Shahjahani; Mohammadi-Asl Javad
Journal:  Cell J       Date:  2015-07-11       Impact factor: 2.479

4.  Administration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy.

Authors:  Hadi Darvishi-Khezri; Mehrnoush Kosaryan; Rosseta Akbarzadeh; Aily Aliasgharian; Mehran Fazli
Journal:  Med Arch       Date:  2018-06

5.  AZD3463, an IGF-1R inhibitor, suppresses breast cancer metastasis to bone via modulation of the PI3K-Akt pathway.

Authors:  Guang-Fu Hu; Cheng Wang; Guang-Xia Hu; Ge Wu; Chengjiao Zhang; Wei Zhu; Cong Chen; Yutong Gu; Hongwei Zhang; Zi'ang Yang
Journal:  Ann Transl Med       Date:  2020-03

Review 6.  A contemporary therapeutic approach to bone disease in beta-thalassemia - a review.

Authors:  Dimitrios Stefanopoulos; Nikolaos A Papaioannou; Athanassios G Papavassiliou; George Mastorakos; Andromachi Vryonidou; Aikaterini Michou; Ismene A Dontas; George Lyritis; Eva Kassi; Symeon Tournis
Journal:  J Frailty Sarcopenia Falls       Date:  2018-03-01

Review 7.  Therapeutic Treatments for Osteoporosis-Which Combination of Pills Is the Best among the Bad?

Authors:  Christian Horst Tonk; Sarah Hani Shoushrah; Patrick Babczyk; Basma El Khaldi-Hansen; Margit Schulze; Monika Herten; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2022-01-26       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.